Accelerate Associates Researches ‘Medical Apps’ for Newcastle University

Newcastle University, Faculty of Medical Sciences Enterprise Team recently selected Accelerate Associates, the Staffordshire based medical device market research company, to assess the current and potential market for Mobile Medical Applications.

Dr Margaret Lawlor from the Enterprise Team at Newcastle started searching for a company to research the Mobile Medical Applications market after researchers at the university had developed a number of ‘medical apps’ in-house.

Accelerate Associates commenced a ten week market research project to identify key developers and market trends within this field. In addition to extensive secondary research, Accelerate Associates liaised with the MHRA (Medicines and Healthcare Products Regulatory Agency) to identify and comment on legislation and regulatory affairs with regards to the mobile medical application market. Interviews with key opinion leaders also provided key intelligence and market perspective.

The end research was completed and delivered to the Enterprise team on schedule and on budget.

“We were delighted to be awarded the research project by the University of Newcastle. Our particular field of expertise involves primary and secondary research in the scientific and medical sectors, so working within the Enterprise Team at the Medical School is a perfect fit for us” explained Katherine Bourne from Accelerate Associates.

“I was delighted with the report and would definitely recommend Accelerate Associates” added Dr Margaret Lawlor, Business Development Manager at Newcastle University Faculty of Medical Sciences. “The report we received exceeded our expectations in terms of the breadth of content. Accelerate Associates clearly highlighted the key success factors to consider when placing a new medical app into the market and this intelligence helped us to determine the best commercial route forward for the University.”


Get the latest Accelerate news

Subscribe to our newsletter to receive an e-mail every now and again with all the latest Accelerate news.